Member Info for ElderlyBird

Malachi. I do not actually write rabid nonsense! Britain sits at the bottom of the League Table for Cancer Survival Rates. Do you not feel the MHRA are dragging their feet? We have both been investors for a number of years. They may feel a sense of urgency but I have yet to see it...... But I do not have the true knowledge of some of our Share Chatters.

I am afraid the FDA and MHRA do not have a good record at making decisions on new systems that will cut down on drugs. In my humble opinion they are too interested in the bottom line. Better and quicker diagnosis = less expensive treatment. Please tell me I am wrong.

We have to face the fact that the FDA will not be in a hurry to grant approval. The sad fact is that Cancer - for them - is a cash cow.
they will not be in a hurry to get it detected sooner.........

Of course the FDA won't agree to Parsortix. It helps early diagnosis of cancer. That is not worth any money to them. They want cancer to go on for ever.

The reason why Angle cannot obtain FDA or MHRA agreement for this product is that it is a significant help to cure Cancer. Cancer is a source of huge income to the pharmaceutical companies. Radio and chemo therapies bring in big returns. A dreadful fact! Elderly Bird